default author photo

Bruno Vincenzi

University Campus Bio-Medico

SCHOLARLY PAPERS

2

DOWNLOADS

352

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Penile Squamous Cell Carcinoma: An International Study from the Global Society of Rare Genitourinary Tumors

Number of pages: 21 Posted: 31 Mar 2023
Harvard University - Lank Center for Genitourinary Oncology, Yale University - Yale New Haven Hospital (YNHH), McMaster University, Emory University - School of Medicine, Emory University School of Medicine - Department of Urology, Emory University - Department of Hematology and Medical Oncology, New York University (NYU) - Grossman School of Medicine, Government of the United States of America - National Cancer Institute, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Arkansas for Medical Sciences, University of Texas at Houston - Department of Melanoma Medical Oncology, Gustave Roussy, Gustave Roussy, University of Parma, Istituto Oncologico Veneto – IRCCS, Ohio State University (OSU) - Comprehensive Cancer Center, Ohio State University (OSU) - The James Comprehensive Cancer Center, Ohio State University (OSU) - The James Comprehensive Cancer Center, Hospital Universitario 12 de Octubre, Hospital Universitario 12 de Octubre, Hospital Universitario 12 de Octubre, University of Florence - Department of Health Sciences, Careggi University Hospital of Florence - Clinical Oncology Unit, University of California, San Diego (UCSD) - Moores Cancer Center, University Campus Bio-Medico, Imperial College London - Hammersmith Hospital, University of California, University of California, Stanford University, Stanford University, Mayo Clinic - Department of Cardiovascular Medicine, Indiana University Purdue University Indianapolis (IUPUI) - Indiana University School of Medicine, Mount Sinai Health System - Division of Hematology and Medical Oncology, Mount Sinai Health System - Icahn School of Medicine, Hospital de la Santa Creu i Sant Pau - Medical Oncology Department, Università degli Studi di Bari “Aldo Moro” (UNIBA), Vanderbilt University - Vanderbilt-Ingram Cancer Center, Duke University - Duke University Hospital, Duke University - Duke University Hospital, National Cancer Centre Singapore, University of Parma, Ruhr University of Bochum - University Hospitals, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) - Clinical and Experimental Oncology Unit, University of Ulsan - Asan Medical Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Pittsburgh - Division of Hematology/Oncology, University of Pittsburgh - Division of Hematology/Oncology, Yale University - Yale New Haven Children's Hospital, Harvard University - Dana-Farber Cancer Institute, Harvard University - Lank Center for Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, National Institutes of Health (NIH) - Bladder Cancer Section and Advent Health Cancer Institute - Division of Medical Oncology
Downloads 245 (311,323)

Abstract:

Loading...

penile cancer, immune checkpoint inhibitors, international cohort, rare disease

2.

A Global CollaboRAtive Study of CIC-Rearranged, BCOR::CCNB3-Rearranged and Other Ultra-Rare Unclassified Undifferentiated Round Cell Sarcomas (GRACefUl)

Number of pages: 26 Posted: 31 Aug 2022
IRCCS Istituto Ortopedico Rizzoli di Bologna - Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Bordeaux - Institut Bergonié, GlaxoSmithKline, University of Texas at Houston - MD Anderson Cancer Center, University College London - University College London Hospitals NHS Foundation Trust, Fondazione IRCCS Istituto Nazionale dei Tumori, Royal Marsden NHS Foundation Trust, Harvard University - Dana-Farber Cancer Institute, Universidad Autónoma de Madrid - FIIS-Fundacion Jimenez Diaz University Hospital, University of Seville - Institute of Biomedicine of Seville, General Hospital, Prato, Candiolo Cancer Institute, IRCCS Regina Elena National Cancer Institute, Istituto Oncologico Veneto – IRCCS, Yeshiva University - Montefiore Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology, Universidad Autónoma de Madrid - FIIS-Fundacion Jimenez Diaz University Hospital, University of Lausanne - Lausanne University Hospital, Kantonsspital St Gallen, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Seville - Institute of Biomedicine of Seville, IRCCS Istituto Ortopedico Rizzoli di Bologna, University Hospital General de Villalba, Harvard University - Dana-Farber Cancer Institute, University Campus Bio-Medico, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Padua - Department of Medicine, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Padua - Department of Medicine, IRCCS Istituto Ortopedico Rizzoli di Bologna, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology and University Campus Bio-Medico
Downloads 107 (654,668)

Abstract:

Loading...

CIC::DUX4, BCOR::CCNB3, ultra rare sarcoma, RNA-seq, undifferentiated round cell sarcoma, soft tissue sarcoma, bone sarcoma, pediatric tumors